Detalles de la búsqueda
1.
Adrenergic microenvironment driven by cancer-associated Schwann cells contributes to chemoresistance in patients with lung cancer.
Cancer Sci
; 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38676373
2.
Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
Jpn J Clin Oncol
; 2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704243
3.
Effective division of the intersegmental plane using a robotic stapler in robotic pulmonary segmentectomy.
Surg Today
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635055
4.
Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Surg Today
; 54(4): 317-324, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523071
5.
Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery.
Surg Today
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451313
6.
Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
Ann Surg Oncol
; 30(13): 8727-8734, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658268
7.
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery.
Ann Surg Oncol
; 30(11): 6697-6702, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355521
8.
Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
Clin Transplant
; 37(11): e15077, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461238
9.
Donor's long-term quality of life following living-donor lobar lung transplantation.
Clin Transplant
; 37(4): e14927, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738289
10.
S100A8/A9 as a prognostic biomarker in lung transplantation.
Clin Transplant
; 37(9): e15006, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37115007
11.
Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor.
J Biol Chem
; 296: 100524, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705793
12.
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
Cancer Sci
; 113(10): 3428-3436, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35871750
13.
Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma.
World J Surg Oncol
; 20(1): 114, 2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35395855
14.
Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression.
Int J Cancer
; 149(8): 1593-1604, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152598
15.
Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice.
Biochem Biophys Res Commun
; 573: 164-170, 2021 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418763
16.
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
Ann Surg Oncol
; 28(9): 4880-4890, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634385
17.
Pulmonary Enteric Adenocarcinoma Harboring a BRAF G469V Mutation.
Acta Med Okayama
; 75(6): 759-762, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34955547
18.
The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas.
Surg Today
; 51(1): 127-135, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32747982
19.
Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery.
Surg Today
; 51(4): 589-594, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880060
20.
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
Int J Mol Sci
; 22(23)2021 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884609